Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression
Bitian Liu, Shen Pan, Junlong Liu, et al.
Gene (2021) Vol. 775, pp. 145451-145451
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation
Thomas Krausgruber, Anna Redl, Daniele Barreca, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 289-306.e7
Open Access | Times Cited: 71
Transcription factors in fibroblast plasticity and CAF heterogeneity
Roberta Melchionna, Paola Trono, Anna Di Carlo, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 24
Pan-cancer landscape of the RUNX protein family reveals their potential as carcinogenic biomarkers and the mechanisms underlying their action
Shen Pan, Siyu Sun, Bitian Liu, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 2, pp. 156-174
Open Access | Times Cited: 37
RUNX2 and Cancer
Tsung‐Chieh Lin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7001-7001
Open Access | Times Cited: 17
RUNX transcription factors: biological functions and implications in cancer
Xinyi Chen, Lu Wang, Mu Yang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes
Ji‐Qing Chen, Lucas A. Salas, John K. Wiencke, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer
Jie Wang, Rehana Akter, Md. Fahim Shahriar, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 21
Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
Yaqi Yang, Qin Liu, Xiyuan Guo, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 19
Phase-specific signatures of wound fibroblasts and matrix patterns define cancer-associated fibroblast subtypes
Mateusz S. Wietecha, David Lauenstein, Michael Cangkrama, et al.
Matrix Biology (2023) Vol. 119, pp. 19-56
Open Access | Times Cited: 10
The Role of Immunosuppressive Cells in TME during the Progression of Bladder Cancer
浩彤 周
Journal of Clinical Personalized Medicine (2025) Vol. 04, Iss. 01, pp. 217-224
Open Access
The Dynamic Interplay between Melanoma Cells and CAFs: Implications Drug Resistance and Immune Evasion and Possible Therapeutics
Chou‐Yi Hsu, Raed Obaid Saleh, Mohammed Sani Jaafaru, et al.
Experimental Cell Research (2025), pp. 114581-114581
Closed Access
Cancer-associated fibroblasts and their role in tumor progression
Mikhail Ermakov, Anna A. Nushtaeva, Vladimir A. Richter, et al.
Vavilov Journal of Genetics and Breeding (2022) Vol. 26, Iss. 1, pp. 14-21
Open Access | Times Cited: 16
ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma
Shiyong Xin, Yanwei Zhang, Zhenhua Zhang, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1201-1220
Closed Access | Times Cited: 2
Immune status for monitoring and treatment of bladder cancer
Shen Pan, Shijie Li, Yunhong Zhan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma
Yiwei Gu, Hui Zhuo
The Aging Male (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 5
The role of cancer-associated fibroblasts in bladder cancer progression
Long Huang, Qun Xie, Jian Deng, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19802-e19802
Open Access | Times Cited: 5
Multiple Roles of the RUNX Gene Family in Hepatocellular Carcinoma and Their Potential Clinical Implications
Milena Krajnović, Bojana Kožik, Ana Božović, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2303-2303
Open Access | Times Cited: 4
Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer
Mohamad Abou Chakra, Yi Luo, Igor Duquesne, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 1
Prognostic value and immune characteristics of RUNX gene family in human cancers: a pan-cancer analysis
Han Zhao, Yun Chen, Peijun Shen, et al.
Aging (2022) Vol. 14, Iss. 9, pp. 4014-4035
Open Access | Times Cited: 4
A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer
Zuhu Yu, Bin Lu, Hong Gao, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 4
Exosomal miR-93-5p from cancer-associated fibroblasts confers malignant phenotypes on bladder cancer cells by targeting PAFAH1B1
Xiaoming Lu, Jinfeng Wang, Binbin Dong, et al.
Anti-Cancer Drugs (2022)
Closed Access | Times Cited: 3
Clinical Significance and Tumor Microenvironment Characterization of a Novel Immune-Related Gene Signature in Bladder Cancer
Zhaohui Wang, Tao Wang, Gangfeng Wu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1892-1892
Open Access | Times Cited: 1
A New Strategy to Authenticate Prognosis and Tumor Immunity Model Based on Cancer-Associated Fibroblasts lncRNA in Bladder Cancer
Hui Zhang, Hui Zhang, Yong Lu, et al.
Journal of Biomedical Nanotechnology (2024) Vol. 20, Iss. 7, pp. 1169-1186
Closed Access
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism
Zhigang Huang, Bin Liu, Xiaoju Li, et al.
Neoplasia (2024) Vol. 60, pp. 101120-101120
Closed Access
Phase-specific signatures of wound fibroblasts and matrix patterns define cancer-associated fibroblast subtypes
Mateusz S. Wietecha, David Lauenstein, Michael Cangkrama, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top